Visionary Holdings Appoints Wenxuan Cai as CEO of GV Hong Kong
Visionary Holdings announced that its wholly owned subsidiary, Visionary Health Technology Group, has official appointed Wenxuan Cai as CEO of GV Hong Kong. In parallel, the GV Hong Kong has established a new wholly owned subsidiary in Nanjing, China, dedicated primarily to sales execution and market development. As CEO of GV Hong Kong, Ms. Cai will focus on: Building and leading regional sales and marketing teams; Executing go-to-market strategies for GV's offerings in the fields of cellular rejuvenation and aesthetic treatment; Expanding institutional, channel, and strategic partnerships; Driving sustainable revenue growth and enhancing sales visibility. The newly established Nanjing entity will serve as frontline commercial platforms, handling regional sales operations and channel development. Combined with GV's Asia-Pacific platform in Hong Kong, the Company has completed a fully integrated commercial structure spanning strategy, products, and sales execution. This development signals that GV's commercialization efforts are now actively operational and scalable.
Trade with 70% Backtested Accuracy
Analyst Views on GV
About GV
About the author

Visionary Holdings Inc. Releases FY 2025 Annual Report with $5.04M Revenue
- Revenue Decline: For FY 2025, Visionary Holdings reported total revenue of $5.04 million, a 46.2% year-over-year decrease primarily due to the contraction of real estate leasing operations and changes in the education policy environment, indicating challenges faced during the transformation process.
- Emerging Business Contribution: Emerging health-related businesses generated $1.06 million in revenue during the reporting period, accounting for 21.1% of total revenue, marking early progress in the company's strategic repositioning despite overall revenue weakness.
- Net Loss Situation: The company reported a net loss of $15.75 million, primarily reflecting one-time transformation-related investments and $4.70 million in asset impairment charges, indicating significant financial pressure during the transition.
- Cash Flow Improvement: Cash flow from investing activities totaled $14.51 million, mainly from asset dispositions, while operating cash outflows decreased to $2.97 million, demonstrating proactive liquidity management efforts by the company.

Visionary Holdings Inc. Releases FY 2025 Annual Report with $5.04M Revenue Decline
- Revenue Decline: Visionary Holdings reported total revenue of $5.04 million for FY 2025, reflecting a 46.2% year-over-year decrease primarily due to a contraction in real estate leasing operations and changes in the education policy environment, indicating challenges faced during the company's transformation.
- Strategic Transformation Progress: The company achieved initial revenue contributions from emerging health-related businesses, accounting for approximately 21.1% of total revenue, suggesting that its business restructuring has entered an early implementation stage with potential new growth avenues ahead.
- Net Loss Situation: The company reported a net loss of $15.75 million, primarily reflecting one-time transformation-related investments and asset impairment charges, highlighting financial pressures and liquidity challenges during the transition period.
- Future Outlook: The company plans to continue exploring commercialization opportunities in health management and anti-aging businesses while optimizing its AI education ecosystem to support business stability and cash flow generation, demonstrating confidence in future market potential.






